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Currently, one of the most controversial areas in pan-creatic islet physiology is the origin of new insulin-
producing -cells that are generated in response to phys-
iological demands postnatally. Harnessing this enigma
would provide newmeans for the treatment of diabetes, a
disease characterized by a gradual loss of-cell mass (type
1 or type 2) and/or a decline in -cell function combined
with insulin resistance (type 2). Restraining destruction
and stimulating regenerationof the functionalmasswould
prevail over hyperglycemia and avoid secondary compli-
cations such as retinopathy and nephropathy and, poten-
tially, cardiovascular and cerebrovascular diseases (1).
Four potential sources of regenerative -cells, with their
respective advocates in perpetual debate, have been pro-
posed to represent the “Fountain ofYouth”: 1) neogenesis
of ductal epithelium cells (2, 3); 2) transdifferentiation of
exocrine acinar cells (4); 3) differentiation of islet-derived
precursor stem cells (5); and 4) -cell replication. Despite
strong evidence for the contribution of neogenesis and
transdifferentiation in various models of animal pancre-
atic injury, recent studies have called into question the role
of these entities in-cellmass expansion in the adult organ
(6, 7). Strong skepticism also remains over the potential
involvement of progenitor stem cells residing within the
pancreas to give rise in vivo to functional-cells (8).How-
ever, -cell replication, which was disregarded for many
years, has lately gained popularity with lineage-tracing
studies, demonstrating that preexisting mouse adult pan-
creatic -cells were the major source of new insulin-pro-
ducing cells during adult life (9).
Consistent with animal work, a limited number of hu-
man islet studies have confirmed that expansion of the
-cell mass in response to metabolic cues occurs predom-
inantly through cell replication (10–13). A common and
important finding of these humanaswell as animal studies
was the correlation between aging and the rapid decline in
cell replication. This suggests that the functional -cell
mass is established early in life and thereafter becomes
quiescent, with a long turnover and limited -cell regen-
erative capacity. Most studies were based on the immu-
nological detection of replicating cells using thymidine
analogs such as 5-bromo-2-deoxyuridine and 5-iodo-2-
deoxyuridine or the proliferationmarker Ki67. However,
labeling analysis can provide information about new cell
formation only at the single cell level. Consequently, it is
difficult to gain a view of the proportion of cells that are
exchangedover timeand toprovide anaccuratebirthdate.
In fact, very few methods exist to determine the life span
of any cell type.One approach employed lipofuscin bodies
(LB) as a marker to estimate -cell longevity. LB accumu-
late in cells with age. Mathematical modeling of LB accu-
mulation demonstrated that the -cell mass was estab-
lished by the age of 20 yr with little adaptive change in
response to obesity and diabetes (14). Although informa-
tive, these data rely on a reconstructed three-dimensional
model of LB and certainly require validation using more
direct and robust experimental methods.
In this issue of JCEM, Perl et al. (15) successfully esti-
mated the birth date, turnover, and longevity of -cells
using conventional in vivo thymidine analog labeling ini-
tially and then themore audacious technique of retrospec-
tivebirthdating. In the first approach, the authorsprofited
from historical clinical trials testing the efficacy of thymi-
dine analogs as radiosensitizer in cancer patients to assess
the degree of -cell proliferation and turnover. Immuno-
cytochemistry studies were performed on samples derived
from 10 deceased patients who had received thymidine
analogs 8 d to 4 yr before death.Only the youngest donors
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(ages 18 and 20 yr) exhibited -cell replication with a
significant annual turnover rate of 30 to 60%, whereas
older donors (ages 31 to 74 yr) showed no analog incor-
poration and thus no cell replication. The authors con-
clude that after age 30, islet -cells lose their plasticity
under their experimental conditions.To substantiate these
findings, Perl et al. (15) used retrospective dating to es-
tablish, for the first time, the birth date of -cells. What
exactly is retrospective dating?During the1950s and early
1960s, the race to nuclear weapons and ultimate world
domination by several nations resulted in a dramatic
global increase in atmospheric levels of the radioisotope
14C. Subsequent to the signing of the ban treaty in 1963,
levels of 14C were found to exponentially decline with a
decrease of 50% approximately every 11 yr due to diffu-
sion aswell as equilibrationwith the environment. Taking
advantageof this humanmischief, Spalding et al. (16)have
shown that the excess 14C integration into DNA closely
correlated with atmospheric levels of the isotope. This re-
lationship was applied to accurately estimate the time
point when DNA was synthesized and the birth date of
cells (Ref. 16 is a “must read”). Retrospective birth dating
is unique because it provides information over the whole
life span of a cell population. Perl et al. (15) successfully
used this approach to estimate that independent of a do-
nor’s age, 14C incorporation into -cell DNA always con-
curred to levels detected in the first three decades of the
individual’s life. Taken together, retrospective birth dat-
ingand thymidine incorporationdemonstrated that: 1) the
average birth date of -cells is within the first 30 yr of life,
with cells having a high rate of turnover; and 2) past the
age of 30, -cell plasticity is lost and remaining cells have
a very long life span (15). Although this study may seem
only confirmatory of recent publications suggesting that
the -cell proliferative capacity is limited to the first 20 yr
of life (or less) (12–14), it is in fact the only one experi-
mentally establishing the age of human -cells. Nonethe-
less, these data require confirmation because the study of
Perl et al. (15)was limited to 10donors for analog labeling
and only three donors for retrospective birth dating due to
technical difficulties in obtaining sufficiently pure DNA
for birth dating by 14C.
This bold study raises important questions such as:why
do -cells become quiescent and long-lived when an indi-
vidual reaches 30?Onepotential explanation for the grad-
ual loss of the replicative capacity of -cells may reside in
the study by Maedler et al. (11) in which a gradual de-
crease in the expression of the islet-enriched transcription
factor Pdx1 was correlated with the age of donors. Pdx1
was shown tobe important not only for-cell functionbut
also for proliferation and survival (17–19). Thus, a de-
crease in Pdx1 levels may contribute to a steady decline in
the capacity of -cells to replicate until the age of 30.
Thereafter, although sufficient topotentially sustain-cell
functions, Pdx1 levels are no longer high enough to reg-
ulate proliferation. It will be of interest to verify this hy-
pothesis and determine whether similar modulations in
expression levels of additional transcription factors im-
plicated in -cell proliferation and survival such as
Nkx6.1, FoxM1, and Pax4 are also detected with increas-
ing age (20–22). Another fundamental question that
arises is whether a 30-yr-old -cell can be recruited to
proliferate in response to physiological or pathophysio-
logical conditions. As rightfully mentioned by Perl et al.
(15), their study unfortunately cannot address this ques-
tion. The obvious physiological condition is pregnancy, in
which insulinoutput is increased to facedemands imposed
by the fetus. This increase was shown to be matched by
expansion of the -cell mass in women (23), suggesting
that indeed -cells can be potentially aroused to replicate.
A recent study has proposed that serotonin may be impli-
cated in regulating -cell mass during pregnancy in mice
(24). It will be of interest to determine whether serotonin
can promote cell replication in human islets isolated from
young as well as old donors. An additional argument in
favor of the ability of-cells to reinitiate proliferation past
30 in a pathophysiological setting is the recent study by
Willcox et al. (25) showing increased islet cell replication
in patientswith recent-onset type 1 diabetes.Of particular
interest was a female donor 42 yr of age, which exhibited
extensive-cell replication. Interestingly, the authors pro-
pose that islet cell proliferationwas reinitiated in response
to immune-derived signals (25). Consistent with this
premise, an independent study recently demonstrated that
-cell replication in nondiabetic donors also correlated
with increased inflammatory infiltration associated with
prolongeddurationon life support (13). Itwill certainly be
of interest to decipher the signals that are involved in reini-
tiating -cell replication over age 30.
Thus, to -e or not to -e replicating after age 30 re-
mains a debatable question that needs to be further vali-
dated experimentally. The study by Perl et al. (15) un-
doubtedly demonstrates that there is significant -cell
turnover only within the first three decades of life under
“normal” physiological conditions. Nonetheless, other
studies clearly show that -cells over 30 can also be re-
cruited to proliferate in response to physiological or
pathophysiological situations (13, 23, 25). The challenge
is now to decipher the molecular networks regulating
-cell proliferation and survival before and after 30 to
develop optimal targeted regenerative therapies for the
treatment of diabetes.
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